Is telehealth allowed to prescribe Wegovy in Florida?

If you’ve been considering medications like Wegovy, Ozempic, or Mounjaro for weight loss, you’ve likely wondered: Can I get these prescribed through telehealth? The short answer is yes—in most cases, you can legally receive GLP-1 weight loss medications through telehealth in the United States. But the longer answer involves understanding federal regulations, state-specific rules, and what makes a telehealth provider legitimate and safe.

This comprehensive guide breaks down everything you need to know about accessing weight loss medications via telehealth in 2025, including state requirements, provider qualifications, safety considerations, and how to avoid red flags.

Understanding Federal Telehealth Rules for Weight Loss Medications

GLP-1 Medications Are Not Controlled Substances

Here’s the most important thing to understand: medications like Wegovy, Ozempic, and Mounjaro are not controlled substances under federal law. This distinction matters because the Drug Enforcement Administration (DEA) has strict rules about prescribing controlled substances (like Adderall or opioids) via telehealth—but those rules do not apply to GLP-1 weight loss medications.

The Ryan Haight Act, which typically requires an in-person examination before prescribing controlled substances via telemedicine, simply doesn’t govern these medications. That means there’s no federal barrier to getting weight loss medications prescribed through a legitimate telehealth visit.

Current Federal Telehealth Flexibilities

While the COVID-19 Public Health Emergency ended in May 2023, the DEA extended telehealth prescribing flexibilities for controlled substances through December 31, 2025. This extension doesn’t directly affect GLP-1 medications (since they were never restricted), but it reflects the federal government’s ongoing support for telehealth as a valid care delivery method.

Congress is also considering legislation like the TREATS Act, which would make certain telehealth prescribing flexibilities permanent—another signal that telemedicine is here to stay for the long haul.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Requirements: Where Can You Get Telehealth Weight Loss Prescriptions?

While federal law allows telehealth prescribing of GLP-1 medications, state laws add an additional layer of requirements. Some states require initial in-person exams, specific follow-up schedules, or additional documentation. Here’s what you need to know about the most common state requirements.

States With No In-Person Requirements

The majority of states allow providers to prescribe weight loss medications entirely through telehealth, with no mandatory in-person visit. These states include:

• California: Full telehealth authorization with no in-person requirement
• Connecticut: Permanent telehealth law; requires behavioral counseling alongside medication
• Illinois: No special restrictions beyond standard prescribing practices
• New York: Explicit telehealth authorization; mandatory e-prescribing
• Pennsylvania: No in-person mandate for weight loss medications
• Washington: Pioneer telehealth state with full remote prescribing allowed

In these states, you can complete your entire evaluation, receive your prescription, and conduct all follow-up appointments via video or phone consultations.

States Requiring Initial In-Person Exams

Several states mandate that patients have at least one in-person physical examination before or shortly after starting telehealth weight loss treatment:

• Arkansas: Must perform first exam in-person (among the most restrictive telehealth laws nationally)
• Delaware: Initial physical exam required before tele-prescribing
• Georgia: In-person exam required prior to telehealth prescriptions
• Mississippi: Initial in-person evaluation mandated for weight management therapy
• New Jersey: Comprehensive in-person exam plus lab work required before prescribing
• North Dakota: Hands-on initial evaluation expected per state medical board guidance
• South Carolina: Must examine patient in person first; periodic evaluations required
• Texas: In-person exam generally expected prior to telehealth prescribing
• Utah: Initial in-person exam encouraged by state guidelines
• Virginia: Must perform physical exam and labs initially, plus 30-day follow-up

If you live in one of these states, you’ll typically need to see a provider in person for your first visit. After establishing care, subsequent appointments can often be conducted via telehealth.

States With Special Requirements

Some states allow telehealth prescribing but impose additional conditions:

Florida requires:

• BMI ≥30 for obesity medication prescribing
• Follow-up visits at least every 3 months during treatment
• Documentation of lifestyle modification attempts

Connecticut mandates:

• Behavioral counseling as part of treatment
• Documented diet and exercise plan

New Jersey and Virginia require:

• Comprehensive initial work-up including labs
• Documented informed consent covering specific risks
• Personalized diet and exercise recommendations

These requirements don’t prevent telehealth prescribing—they just ensure providers maintain appropriate clinical standards during remote care.

Who Can Prescribe Weight Loss Medications Via Telehealth?

Physicians (MDs and DOs)

All states allow licensed Medical Doctors (MDs) and Doctors of Osteopathic Medicine (DOs) to prescribe GLP-1 weight loss medications via telehealth, assuming they hold an active medical license in your state. Physicians have the broadest prescribing authority and face the fewest restrictions.

Nurse Practitioners (NPs)

Nurse Practitioners can prescribe weight loss medications in all 50 states, but their level of autonomy varies significantly:

Independent Practice States (NPs can prescribe without physician oversight):

• California (after 3+ years experience)
• Connecticut (after 3 years collaboration)
• Delaware (after 2 years collaboration)
• New York (after 3,600 supervised hours)
• Utah (full practice as of 2023)
• Virginia (after 2 years collaboration)
• Washington (full independent practice)

Collaborative Practice States (NPs require physician agreement):

• Arkansas (APRN must have MD agreement)
• Florida (limited independence in primary care only)
• Georgia (now can prescribe Schedule II with delegation)
• Illinois (written MD agreement required)
• Mississippi (physician collaboration required)
• New Jersey (joint protocol with physician)
• Pennsylvania (physician collaboration required)
• South Carolina (MD supervision with written protocol)
• Texas (MD delegation required; very strict oversight)

As of 2025, 34 states plus DC have granted NPs full independent practice authority. This trend continues to expand, making NP-delivered telehealth increasingly accessible.

Physician Assistants (PAs)

Physician Assistants can also prescribe GLP-1 medications in all states, though they typically work under some form of physician supervision or collaboration. The specific requirements vary by state but are generally similar to NP rules.

When you use a telehealth service like Klarity Health, you can trust that the provider—whether an MD, DO, NP, or PA—is appropriately licensed and credentialed to prescribe in your state.

Understanding GLP-1 Weight Loss Medications

Wegovy (Semaglutide 2.4mg)

• FDA Status: Approved specifically for chronic weight management
• Schedule: Unscheduled (not a controlled substance)
• Eligibility: BMI ≥30, or BMI ≥27 with weight-related comorbidities
• Typical Supply: 30-day starter dose; up to 90 days once stable
• Special Notes: Should be prescribed alongside lifestyle counseling; FDA banned most compounded versions in May 2025

Ozempic (Semaglutide 0.5-1mg)

• FDA Status: Approved for Type 2 diabetes; used off-label for weight loss
• Schedule: Unscheduled
• Eligibility: Same as Wegovy when used off-label
• Typical Supply: 30-day trial doses
• Special Notes: Providers must document off-label rationale and obtain informed consent; same active ingredient as Wegovy

Mounjaro/Zepbound (Tirzepatide)

• FDA Status: Mounjaro approved for diabetes; Zepbound approved for obesity
• Schedule: Unscheduled
• Eligibility: Standard obesity criteria
• Typical Supply: 30-day titration packs
• Special Notes: Newer dual-action GLP-1/GIP medication; requires self-injection training

All three medications are fully prescribable via telehealth under federal law, though state requirements may vary as outlined above.

Patient Eligibility: Who Qualifies for Telehealth Weight Loss Medications?

Clinical Criteria

Legitimate telehealth providers will screen carefully to ensure you meet medical criteria:

Generally Required:

• BMI ≥30 (obesity), OR
• BMI ≥27 with at least one weight-related health condition (diabetes, hypertension, dyslipidemia, sleep apnea)
• Age 18+ (adult patients)
• Documented attempts at lifestyle modification (diet, exercise) unless medically inadvisable

Medical History Assessment:

• Current medications and allergies
• Previous weight loss attempts
• Relevant medical conditions
• Family medical history

Contraindications and Disqualifications

You will not qualify for GLP-1 therapy if you have:

• Personal or family history of medullary thyroid carcinoma (all GLP-1s carry FDA boxed warning)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Current pregnancy or planning to become pregnant (must discontinue 2 months before conception)
• Active gallbladder disease
• History of pancreatitis
• Severe gastrointestinal disorders (e.g., gastroparesis)

Reputable telehealth providers will screen for these conditions during your initial evaluation.

Common Misconceptions About Eligibility

Myth: ‘Anyone can get Ozempic online for quick weight loss.’

Reality: Legitimate providers conduct thorough medical evaluations. If you’re only slightly overweight or seeking cosmetic weight loss without medical necessity, ethical providers will recommend lifestyle modifications instead of medication.

Myth: ‘These are just diet pills I can take casually.’

Reality: GLP-1 medications are powerful therapeutics requiring ongoing monitoring. They work gradually over months and must be part of a comprehensive treatment plan including diet and exercise changes.

The Telehealth Evaluation Process: What to Expect

Initial Consultation

A legitimate telehealth weight loss evaluation typically includes:

1. Detailed Medical Questionnaire

• Complete health history
• Current medications and supplements
• Previous weight loss attempts
• Diet and exercise habits
• Mental health screening

1. Live Video Consultation

• Discussion of weight loss goals
• Review of medical history
• Vital signs review (height, weight, blood pressure)
• Risk-benefit discussion
• Side effect education

1. Informed Consent

• Documentation of potential side effects (nausea, GI upset, gallstone risk)
• Discussion of alternatives
• Explanation of treatment plan
• Commitment to lifestyle changes

Documentation Requirements

Providers must document:

• Rationale for prescribing (BMI, comorbidities)
• Informed consent
• Treatment plan including diet/exercise recommendations
• Baseline labs (may require in-person lab work)
• Contraindication screening

Many states explicitly require this documentation as part of telehealth standard of care.

Follow-Up Schedule

Standard monitoring typically includes:

• 1 month after starting: Assess tolerance, side effects, initial weight response
• Every 2-3 months thereafter: Monitor weight loss progress, adjust dose, review side effects
• Periodic labs: Metabolic panel, A1C (if diabetic), lipid panel

Some states mandate specific follow-up schedules:

• Florida: At least every 3 months
• Virginia: Within 30 days of starting therapy

Prescription and Dispensing

Once approved, your provider will:

• Send electronic prescription to your chosen pharmacy
• Provide injection training (video or written instructions)
• Schedule follow-up appointment
• Offer ongoing support between visits

Initial prescriptions are typically for 4 weeks to assess tolerance. Subsequent prescriptions may be 1-3 months depending on your progress and state regulations.

How Klarity Health Supports Your Weight Loss Journey

At Klarity Health, we’ve designed our telehealth platform to provide safe, effective, and accessible weight loss care:

Provider Availability

Our network includes board-certified physicians and licensed nurse practitioners across multiple states, ensuring you can connect with a qualified provider in your location. With flexible appointment scheduling, including evening and weekend options, we make it easy to fit care into your busy life.

Transparent Pricing

We believe healthcare costs should be clear from the start. Klarity offers upfront, transparent pricing for consultations and follows your insurance benefits when available. We also accept cash pay options for those without insurance or who prefer self-pay.

Insurance and Payment Flexibility

We work with most major insurance plans and can help you understand your coverage for both telehealth visits and medications. For those paying out-of-pocket, we offer competitive cash rates and can direct you to prescription savings programs.

Comprehensive Care Approach

Weight loss medication is just one part of a successful treatment plan. Klarity providers emphasize lifestyle counseling, ongoing support, and regular monitoring to help you achieve sustainable results. We’re committed to your long-term health, not just writing prescriptions.

Red Flags: How to Spot Illegitimate Telehealth Weight Loss Services

The popularity of GLP-1 medications has unfortunately attracted some questionable operators. Protect yourself by watching for these warning signs:

Guaranteed Prescriptions Without Evaluation

Red Flag: Services that promise you’ll get a prescription before completing any medical assessment.

Why It Matters: Legitimate providers must evaluate whether you medically qualify and ensure these medications are safe for you.

Selling Compounded or Overseas Versions

Red Flag: Offers for ‘cheaper’ compounded semaglutide or medications shipped from overseas pharmacies.

Why It Matters: The FDA banned most compounded semaglutide in May 2025 due to safety concerns. Overseas medications may not contain what they claim and bypass safety regulations.

No Follow-Up or Monitoring

Red Flag: Services that prescribe medication but don’t schedule follow-up appointments or monitor your progress.

Why It Matters: GLP-1 medications require ongoing monitoring for side effects, dose adjustments, and weight loss progress. Prescribe-and-forget approaches violate standard of care.

Unclear Provider Credentials

Red Flag: Websites that don’t clearly state who will be prescribing, what licenses they hold, or which states they’re authorized in.

Why It Matters: Your prescriber must be licensed in your state. Legitimate services prominently display provider qualifications.

Skipping Risk Discussions

Red Flag: Services that don’t discuss side effects, contraindications, or alternatives before prescribing.

Why It Matters: Informed consent is legally required and ethically essential. You deserve to understand what you’re taking and potential risks.

Missing Contact Information

Red Flag: No physical address, phone number, or clear way to contact the service with concerns.

Why It Matters: Legitimate healthcare providers have transparent operations and accessible support.

Choose established telehealth providers like Klarity Health that prioritize patient safety, regulatory compliance, and comprehensive care over quick prescriptions.

The Future of Telehealth Weight Loss Care

Regulatory Trends

The trajectory is clear: telehealth is expanding, not contracting. Key developments to watch:

• DEA rules: The current telehealth extension for controlled substances runs through December 31, 2025, with signals pointing toward another extension or permanent rules in 2026
• State harmonization: More states are joining interstate licensure compacts, making it easier for providers to serve patients across state lines
• Congressional support: Bills like the TREATS Act show bipartisan support for permanent telehealth flexibilities
• NP practice authority: The trend toward independent practice for nurse practitioners continues, with several states considering expansion bills in 2025-2026

Technology Innovations

Expect continued improvements in telehealth platforms:

• Enhanced remote monitoring capabilities
• Integration with wearable devices and home health tools
• AI-assisted health assessments (always with human provider oversight)
• Improved medication delivery and tracking systems

Access Expansion

As regulations stabilize and technology improves, more Americans will have access to convenient, affordable weight loss care through telehealth—particularly those in rural areas or with mobility limitations who previously faced barriers to specialty obesity treatment.

Frequently Asked Questions

Q: Do I need to be on camera for my telehealth weight loss appointment?

A: Most states require live video (audio and visual) for telehealth prescribing to establish a proper patient-provider relationship. Audio-only phone calls typically don’t meet regulatory requirements for prescribing medications.

Q: Can my provider prescribe weight loss medication if I live in a different state?

A: Your provider must be licensed in the state where you are physically located during the appointment. Many telehealth services employ providers licensed in multiple states to serve patients nationwide.

Q: Will my insurance cover telehealth weight loss appointments?

A: Many insurance plans now cover telehealth visits at the same rate as in-person appointments. However, coverage for the weight loss medications themselves varies widely by plan. Contact your insurer or check with your telehealth provider about coverage.

Q: How long does it take to get a prescription after my telehealth visit?

A: If you qualify, most providers send prescriptions electronically to your pharmacy immediately after your appointment. You can typically pick up your medication within 24-48 hours, depending on pharmacy stock.

Q: What if I need to see a doctor in person for blood work?

A: Your telehealth provider can order labs at a local facility near you. You’ll visit the lab in person for blood draws, and results will be sent to your telehealth provider for review.

Take the Next Step Toward Your Weight Loss Goals

Telehealth has revolutionized access to weight loss medications, making expert care convenient, affordable, and accessible from the comfort of your home. Whether you’re struggling with obesity, managing weight-related health conditions, or seeking support for sustainable weight loss, legitimate telehealth services can connect you with qualified providers who understand your needs.

Ready to explore your options? Klarity Health offers comprehensive telehealth weight loss consultations with licensed providers who take the time to understand your health history, answer your questions, and develop personalized treatment plans. With transparent pricing, flexible appointment scheduling, and both insurance and cash pay options, we make quality care accessible.

Don’t let confusion about regulations or concerns about legitimacy hold you back. Choose a trusted telehealth partner committed to your safety and success. Schedule your confidential consultation with Klarity Health today and take the first step toward a healthier you.

Research Currency Statement

Verified as of: December 17, 2025

DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025. Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.

States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of Dec 2025)

Sources Currency: 15 of 18 sources are from 2024-2025; older sources used only for baseline context

⚠️ Note: Federal telehealth rules for controlled substances are temporary (set to expire 12/31/2025) – an additional extension or new rule is expected. State laws continue to evolve; watch for changes in 2026, including pending NP practice authority bills and potential federal legislation like the TREATS Act.

Citations

1. DEA and HHS Extend Telemedicine Flexibilities through 2025 – U.S. Drug Enforcement Administration, November 15, 2024. www.dea.gov

2. COVID-era telehealth prescribing extended for Adderall and other controlled substances – Axios, November 18, 2024. www.axios.com

3. Changing Regulatory and Reimbursement Landscape for Anti-Obesity Medications – Goodwin Procter LLP, March 27, 2024. www.goodwinlaw.com

4. DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing – McDermott Will & Emery, November 18, 2024. www.mwe.com

5. Hims Cuts 4% of Workforce Amid Ban on Weight-Loss Drug Copies – Reuters, May 30, 2025. www.reuters.com

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid